Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy.

Retina (Philadelphia, Pa.) - 1 Jan 2000

Sakurada Yoichi, Kubota Takeo, Imasawa Mitsuhiro, Mabuchi Fumihiko, Tanabe Naohiko, Iijima Hiroyuki

Abstract excerpt

PURPOSE: To investigate whether there is an association of the LOC387715 A69S genotype with visual prognosis after photodynamic therapy in eyes with polypoidal choroidal vasculopathy (PCV). METHODS: Photodynamic therapy was repeated every 3 months until the disappearance of angiographic signs of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Choroid
Share to Choroid Diseases
Share to Coloring Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorescein Angiography

Share to Peripheral Vascular Diseases

Share to Photochemotherapy

Share to Photosensitizing Agents

Share to Porphyrins

Source

Identifiers

PMID: 20671585
DOI: 10.1097/IAE.0b013e3181e587e3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20671585-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy.PMID 20671585Read ↗

LOC387715/HTRA1 variants and the response to combined photodynamic therapy with intravitreal bevacizumab for polypoidal choroidal vasculopathy.Semantic proximity Read ↗

Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy.Semantic proximity Read ↗

Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapy.Semantic proximity Read ↗

Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.Semantic proximity Read ↗

The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers.Semantic proximity Read ↗

Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy.Semantic proximity Read ↗

Meta-analysis of the relationship between the LOC387715/ARMS2 polymorphism and polypoidal choroidal vasculopathy.Semantic proximity Read ↗

LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population.Semantic proximity Read ↗

Ethnic Differences on Long Term Outcomes of Polypoidal Choroidal Vasculopathy after Predominantly Bevacizumab Monotherapy.Semantic proximity Read ↗

Genetic predictors of response to photodynamictherapy.Semantic proximity Read ↗

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.Semantic proximity Read ↗

Genetic Risk Factors for Radiation Vasculopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.